CONTENTS:
- Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic review. Russell C., Ashley J., Ali F., Bozinoff N., Corace K., Marsh D.C., et al., art. 104343.
- Alcohol policy changes during the first three-months of the COVID-19 pandemic: Development and application of a classification scheme. Pena S., Wilkinson C., Aresi G., Barrett L., Boniface S., Fitzgerald N., et al., art. 104373.
- Vaccination coverage among people who inject drugs: A systematic review. Price O., Swanton R., Grebely J., Hajarizadeh B., Webb P., Peacock A., et al., art. 104382.
- Alcohol industry-sponsored music festivals, alcohol marketing and drinking practices among young Nigerians: Implications for policy. Dumbili E.W., art. 104384.
- How have cannabis use and related indicators changed since legalization of cannabis for non-medical purposes? Results of the Canadian Cannabis Survey 2018–2022. Goodman S., Dann M.J., Fataar F., Abramovici H., art. 104385.
- Acceptability and anticipated effectiveness of a safe supply of opioids, among people who inject opioids in King County, WA. Palayew A., Banta-Green C.J., Lamont M., Damper D., Moreno C., Goodreau S.M., et al., art. 104389.
- 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial. Farrell M., Shahbazi J., Chambers M., Byrne M., Gholami J., Zahra E., et al., art. 104390.
- "It gets you high as a kite but not unsick": Characterizations of and responses to a changing local drug supply by people who use drugs in Rhode Island. Collins A.B., Macon E.C., Levin S., Wunsch C., Wightman R.S., art. 104391.
- Trends in opioid toxicities among people with and without opioid use disorder and the impact of the COVID-19 pandemic in Ontario, Canada: A population-based analysis. Ledlie S., Tadrous M., Bayoumi A.M., McCormack D., Cheng C., Besharah J., et al., art. 104392.
- 'It has gotten a lot better, but it is still bad': Experiences with the police among marginalized PWUDs in a context of depenalization. Kammersgaard T., Kappel N., Johansen K.S., Kronbaek M., Fahnoe K.R., Houborg E., art. 104393.
- Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study. Valerio H., Marshall A.D., Conway A., Treloar C., Carter L., Martinello M., et al., art. 104394.
- Uneven effects of twenty years of Chile's cannabis policy implementation in cannabis onset. Nazif-Munoz J.I., Dominguez-Cancino K., Martinez P., Jauffret-Roustide M., art. 104395.
- Slicing through silos: Development and evaluation of a hospital-based telehealth hepatitis C virus treatment program. Babiarz J., Ryu H., Williams C., Ham Y., Rivera Sarti J., Levander X.A., art. 104396.
- Exploring practices to enhance benefits and reduce risks of chemsex among gay, bisexual, and other men who have sex with men: A meta-ethnography. Hawkinson D.E., Witzel T.C., Gafos M., art. 104398.
- The dynamics of more-than-human care in depot buprenorphine treatment: A new materialist analysis of Australian patients' experiences. Barnett A., Pienaar K., Lubman D.I., Arunogiri S., Phan V., Hayes V., et al., art. 104399.
- Patterns of delta 8 THC and cannabis uptake in Nebraska: A cannabis prohibition state. Humeniuk R., Habecker P., Cooper-Ohm S., Bevins R.A., art. 104400.
- Beyond the smoke: Historical analysis of the revenue implications of state cigarette tax policies, 1989 to 2019. Azagba S., Ebling T., Korkmaz A., art. 104408.
- Drugs, guns, and violent crime in California. Stewart S.L., Kagawa R.M.C., Buggs S.A.L., Wright M.A., Wintemute G.J., art. 104413.
- How is alcohol consumption and heavy episodic drinking spread across different types of drinking occasion in Great Britain: An event-level latent class analysis. Holmes J., Sasso A., Hernandez Alava M., Borges Neves R., Stevely A.K., Warde A., et al., art. 104414.
- Overcoming stigma: Community support for overdose prevention sites. Grisamore S.P., DeMatteo D., art. 104415.
- The return of drugs courts: Some important considerations. Ward D.J., Kawalek D.A., art. 104418.
- "Everybody is impacted. Everybody's hurting": Grief, loss and the emotional impacts of overdose on harm reduction workers. Kolla G., Khorasheh T., Dodd Z., Greig S., Altenberg J., Perreault Y., et al., art. 104419.
- Time for Australia to increase take away doses in opioid agonist treatment. FitzGerald G., MacCartney P., Cook J., Crawford S., Naren T., art. 104420.
- Reflections on editing the International Journal of Drug Policy: The limits and power of research evidence [Editorial]. Ritter A., art. 104421.
- Mapping a moral panic: News media narratives and medical expertise in public debates on safer supply, diversion, and youth drug use in Canada. Michaud L., Kolla G., Rudzinski K., Guta A., art. 104423.
- Smoking out Australia's growing illicit tobacco market: Current trends and future challenges. Puljevic C., King M., Meciar I., Gartner C., art. 104424.
- Towards a social harm approach in drug policy. Dertadian G.C., Askew R., art. 104425.
- What are the impacts of alcohol supply reduction measures on police-recorded adult domestic and family violence in the Northern Territory of Australia? Clifford S., Wright C.J.C., Miller P.G., Coomber K., Griffiths K.E., Smith J.A., et al., art. 104426.